4D Molecular Therapeutics Inc

NASDAQ:FDMT   4:00:00 PM EDT
31.86
-4.01 (-11.18%)
7:59:46 PM EDT: $31.00 -0.86 (-2.70%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.59B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.99 Million
Adjusted EPS-$0.74
See more estimates
10-Day MA$32.81
50-Day MA$26.85
200-Day MA$18.46
See more pivots

4D Molecular Therapeutics Inc Stock, NASDAQ:FDMT

5858 Horton Street, Suite 455, Emeryville, California 94608
United States of America
Phone: +1.510.505.2680
Number of Employees: 147

Description

4D Molecular Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of unlocking the full potential of genetic medicines to treat large market diseases in ophthalmology and pulmonology. The firm also offers product candidates focused on large market ophthalmology, pulmonology, and cardiology. The company was founded by David H. Kirn, Melissa Kotterman, Theresa Janke, and David Schaffer on September 12, 2013 and is headquartered in Emeryville, CA.